ESC 2022

ECpella versus ECMO in Cardiogenic Shock: Two Independent Meta-analyses

Mario Iannaccone, MD and Vasileios Panoulas, MD, discuss two meta-analyses demonstrating improved survival in cardiogenic shock managed with ECMO and Impella (ECpella™) versus ECMO alone.

Sign up for Latest HeartRecovery Updates

Register for our newsletter and stay tuned for latest news about Impella devices, clinical evidence and events.

HeartRecovery @ ESC 365

Part 4 - Access management and device-related complications

Moderator: Prof. Dariusz Dudek

Speakers: Prof. Alain Combes and Prof. Nicolas van Mieghem

Discover Past Events

Discover past events @ ESC 365.

CAMP PCI™

CAMP was developed by physicians for physicians in an effort to respond to a growing crisis in coronary artery disease and heart failure. Dedicated to improving interventional cardiologists patient outcomes and quality of life with supported high-risk PCI by utilizing best practices, techniques and technologies to enable safer, more effective and complete revascularization.

Joint EAPCI/ACVC Expert Consensus Document

on percutaneous ventricular assist devices

Protected PCI

Learn more about protected PCI.

Surgical Applications

Learn more about surgical applications for Impella® heart pumps.

AMI Cardiogenic Shock

Learn more about Impella® heart pumps and cardiogenic shock.

Right-sided Heart Failure

Learn more about Impella® RP and right-sided heart failure.

Native Heart and Lung Recovery

Conditions & Therapies

Access education, clinical evidence and practice support for Protected PCI, AMI cardiogenic shock, right heart failure, surgical applications and severe lung failure.

Products & Services

Learn about the latest technology and how that technology may best support your patient.

Education & Resources

Abiomed provides a comprehensive training program for health care providers.

NPS-2641

The Protected PCI community
is now on HeartRecovery.com